Jennifer F Bock-Hughes, MD
Otolaryngology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 4 carriers
- Office
- 1
- Since medical school
- 37 years
- Yale University School of Medicine, 1989
Offices
1 location · Regents of the University of California - UCSF · 78 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bock-Hughes’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G71603 · Current
Licensed to practise in California · since 1991 · expires 2028-08-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$123,335
Medicare paid this office $123,335 for 611 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 412 | $49,843 | $83 |
| Removal of impacted ear wax | 417 | $25,244 | $45 |
| New patient visit (45+ min) | 83 | $13,069 | $157 |
| Return visit (30+ min) | 90 | $11,487 | $120 |
| New patient visit (30+ min) | 113 | $10,073 | $89 |
See all 8 services
| Short return visit (20+ min) | 412 | $49,843 | $83 |
| Removal of impacted ear wax | 417 | $25,244 | $45 |
| New patient visit (45+ min) | 83 | $13,069 | $157 |
| Return visit (30+ min) | 90 | $11,487 | $120 |
| New patient visit (30+ min) | 113 | $10,073 | $89 |
| Diagnostic exam of voice box using a flexible endoscope | 32 | $4,495 | $136 |
| Test to assess middle ear function | 13 | $173 | $13 |
| Injection of drug or substance under skin or into muscle | 12 | $152 | $13 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 414 | 382 | 517 | 540 | 568 | 564 |
| Diagnostic exam of voice box using a flexible endoscope | 70 | 34 | 41 | 65 | 61 | 33 |
| Diagnostic exam of nasal passages using an endoscope | 31 | 15 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
611 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 22% · Women 58% · Also on Medicaid 4% · Health risk score 1.04. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 68% · Diabetes 21% · Coronary heart disease 21% · Chronic kidney disease 19% · Atrial fibrillation 17% · Cancer 16% · Heart failure 11% · COPD 10% · Depression 10% · Stroke 5% · Dementia 4%.
The office billed $315,723, Medicare allowed $169,092 and paid $123,335; for 1,763 services of 23 kinds; $47 of it was for drugs given in the office and $123,288 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 611 | 1,763 | 78 | 1.04 | $315,723 | $123,335 |
| 2023 | 601 | 1,685 | 78 | 1.00 | $314,250 | $121,249 |
| 2022 | 608 | 1,636 | 78 | 0.95 | $306,342 | $114,804 |
| 2021 | 589 | 1,545 | 78 | 0.94 | $281,565 | $110,786 |
| 2020 | 493 | 1,240 | 78 | 0.97 | $224,951 | $77,321 |
| 2019 | 542 | 1,519 | 77 | 1.05 | $314,264 | $105,488 |
| 2018 | 509 | 1,395 | 77 | 1.02 | $299,196 | $99,721 |
| 2017 | 548 | 1,601 | 77 | 1.12 | $330,449 | $109,815 |
| 2016 | 651 | 1,829 | 77 | 1.10 | $372,215 | $136,795 |
| 2015 | 451 | 1,407 | 77 | 1.08 | $265,642 | $109,535 |
| 2014 | 453 | 1,414 | 76 | 1.10 | $236,708 | $97,273 |
| 2013 | 442 | 1,459 | 77 | 0.98 | $250,703 | $106,309 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 413 | $46,109 | $77 |
| Removal of impacted ear wax | 405 | $23,900 | $42 |
| New patient visit (30+ min) | 127 | $11,851 | $93 |
| Return visit (30+ min) | 83 | $10,600 | $114 |
| New patient visit (45+ min) | 76 | $10,217 | $134 |
| Diagnostic exam of voice box using a flexible endoscope | 59 | $7,973 | $131 |
| Long return visit (40+ min) | 13 | $1,911 | $147 |
| Exam of ear using a microscope | 11 | $412 | $29 |
| Test to assess middle ear function | 23 | $362 | $16 |
| Injection, methylprednisolone acetate, 80 mg | 26 | $246 | None |
| Injection of drug or substance under skin or into muscle | 17 | $240 | $13 |
2022: 12 services
| Short return visit (20+ min) | 384 | $40,576 | $74 |
| Removal of impacted ear wax | 400 | $21,619 | $40 |
| Return visit (30+ min) | 101 | $12,225 | $109 |
| New patient visit (45+ min) | 83 | $11,320 | $136 |
| New patient visit (30+ min) | 116 | $9,864 | $85 |
| Diagnostic exam of voice box using a flexible endoscope | 59 | $8,472 | $130 |
| Exam of the nose and throat using an endoscope | 12 | $1,503 | $125 |
| Short return visit | 26 | $1,472 | $41 |
| Exam of ear using a microscope | 13 | $896 | $29 |
| Test to assess middle ear function | 16 | $242 | $14 |
| Injection of drug or substance under skin or into muscle | 14 | $198 | $14 |
| Injection, methylprednisolone acetate, 80 mg | 20 | $182 | None |
2021: 10 services
| Short return visit (20+ min) | 329 | $33,520 | $79 |
| Removal of impacted ear wax | 393 | $21,440 | $41 |
| Return visit (30+ min) | 105 | $13,200 | $115 |
| New patient visit (45+ min) | 75 | $11,064 | $148 |
| New patient visit (30+ min) | 108 | $10,518 | $97 |
| Short return visit | 95 | $5,885 | $49 |
| Diagnostic exam of voice box using a flexible endoscope | 39 | $5,319 | $130 |
| Exam of ear using a microscope | 13 | $555 | $29 |
| Injection, methylprednisolone acetate, 80 mg | 27 | $230 | None |
| Injection of drug or substance under skin or into muscle | 15 | $182 | $11 |
2020: 11 services
| Short return visit (20+ min) | 315 | $27,067 | $63 |
| Removal of impacted ear wax | 292 | $15,475 | $41 |
| New patient visit (30+ min) | 148 | $12,377 | $84 |
| New patient visit (45+ min) | 43 | $5,251 | $122 |
| Return visit (30+ min) | 44 | $4,485 | $100 |
| Diagnostic exam of voice box using a flexible endoscope | 34 | $3,930 | $116 |
| Diagnostic exam of nasal passages using an endoscope | 15 | $2,658 | $177 |
| Short return visit | 30 | $1,405 | $37 |
| Exam of ear using a microscope | 22 | $1,110 | $30 |
| Injection of drug or substance under skin or into muscle | 16 | $192 | $12 |
| Injection, methylprednisolone acetate, 80 mg | 18 | $147 | None |
2019: 11 services
| Short return visit (20+ min) | 349 | $31,448 | $65 |
| Removal of impacted ear wax | 316 | $16,679 | $40 |
| New patient visit (30+ min) | 125 | $11,128 | $89 |
| New patient visit (45+ min) | 68 | $9,052 | $133 |
| Return visit (30+ min) | 77 | $8,721 | $97 |
| Diagnostic exam of voice box using a flexible endoscope | 61 | $7,960 | $114 |
| Diagnostic exam of nasal passages using an endoscope | 27 | $6,119 | $197 |
| Short return visit | 32 | $1,627 | $40 |
| Exam of ear using a microscope | 24 | $994 | $28 |
| Injection of drug or substance under skin or into muscle | 39 | $641 | $15 |
| Injection, methylprednisolone acetate, 80 mg | 41 | $416 | None |
2018: 12 services
| Short return visit (20+ min) | 317 | $27,453 | $61 |
| Removal of impacted ear wax | 276 | $14,473 | $41 |
| New patient visit (45+ min) | 76 | $10,217 | $134 |
| Return visit (30+ min) | 87 | $8,992 | $90 |
| Diagnostic exam of voice box using a flexible endoscope | 64 | $8,500 | $106 |
| New patient visit (30+ min) | 99 | $8,373 | $85 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $6,921 | $210 |
| Short return visit | 38 | $1,645 | $36 |
| Exam of ear using a microscope | 20 | $655 | $26 |
| Injection of drug or substance under skin or into muscle | 12 | $243 | $19 |
| Injection, methylprednisolone acetate, 80 mg | 17 | $185 | None |
| Test to assess middle ear function | 15 | $178 | $12 |
2017: 13 services
| Short return visit (20+ min) | 375 | $28,321 | $56 |
| Removal of impacted ear wax | 318 | $15,988 | $39 |
| New patient visit (45+ min) | 81 | $11,528 | $142 |
| Return visit (30+ min) | 83 | $8,841 | $85 |
| New patient visit (30+ min) | 102 | $8,840 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 68 | $8,817 | $108 |
| Diagnostic exam of nasal passages using an endoscope | 38 | $8,308 | $203 |
| Short return visit | 32 | $1,812 | $38 |
| Exam of the nose and throat using an endoscope | 13 | $1,167 | $90 |
| Injection of drug or substance under skin or into muscle | 31 | $750 | $23 |
| Exam of ear using a microscope | 23 | $726 | $28 |
| Injection, methylprednisolone acetate, 80 mg | 32 | $267 | None |
| Test to assess middle ear function | 16 | $193 | $11 |
2016: 13 services
| Short return visit (20+ min) | 388 | $35,088 | $63 |
| Removal of impacted ear wax | 353 | $20,260 | $43 |
| New patient visit (30+ min) | 188 | $17,029 | $91 |
| New patient visit (45+ min) | 91 | $12,980 | $143 |
| Diagnostic exam of voice box using a flexible endoscope | 72 | $10,375 | $109 |
| Return visit (30+ min) | 90 | $9,645 | $91 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $5,982 | $214 |
| Exam of the nose and throat using an endoscope | 40 | $5,004 | $116 |
| Short return visit | 47 | $2,412 | $38 |
| New patient visit (60+ min) | 11 | $1,800 | $164 |
| Exam of ear using a microscope | 18 | $837 | $31 |
| Injection of drug or substance under skin or into muscle | 20 | $423 | $21 |
| Injection, methylprednisolone acetate, 80 mg | 23 | $149 | None |
2015: 12 services
| Short return visit (20+ min) | 299 | $29,605 | $61 |
| New patient visit (45+ min) | 102 | $13,679 | $134 |
| Removal of impacted ear wax | 231 | $12,901 | $43 |
| Return visit (30+ min) | 74 | $8,376 | $94 |
| Diagnostic exam of voice box using a flexible endoscope | 67 | $8,137 | $108 |
| New patient visit (30+ min) | 70 | $6,103 | $87 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $3,564 | $188 |
| Short return visit | 27 | $1,399 | $40 |
| Exam of ear using a microscope | 25 | $1,232 | $28 |
| Injection of drug or substance under skin or into muscle | 23 | $540 | $23 |
| Test to assess middle ear function | 13 | $180 | $13 |
| Injection, methylprednisolone acetate, 80 mg | 24 | $114 | None |
2014: 12 services
| Short return visit (20+ min) | 276 | $25,881 | $62 |
| Removal of impacted ear wax | 232 | $13,075 | $41 |
| Return visit (30+ min) | 107 | $12,386 | $94 |
| New patient visit (30+ min) | 102 | $9,020 | $88 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $8,129 | $111 |
| New patient visit (45+ min) | 30 | $4,229 | $141 |
| New patient visit (15+ min) | 51 | $3,020 | $59 |
| Exam of ear using a microscope | 23 | $1,389 | $30 |
| Short return visit | 29 | $1,297 | $37 |
| Injection of drug or substance under skin or into muscle | 25 | $636 | $22 |
| Test to assess middle ear function | 23 | $325 | $13 |
| Injection, methylprednisolone acetate, 80 mg | 25 | $118 | None |
2013: 14 services
| Short return visit (20+ min) | 279 | $27,609 | $64 |
| Removal of impacted ear wax | 236 | $13,918 | $44 |
| Diagnostic exam of voice box using a flexible endoscope | 66 | $8,342 | $113 |
| New patient visit (30+ min) | 93 | $8,200 | $88 |
| Diagnostic exam of nasal passages using an endoscope | 20 | $7,346 | $216 |
| Return visit (30+ min) | 66 | $7,030 | $90 |
| New patient visit (45+ min) | 43 | $5,960 | $139 |
| Short return visit | 75 | $3,352 | $33 |
| New patient visit (15+ min) | 26 | $1,834 | $71 |
| Exam of ear using a microscope | 26 | $1,349 | $30 |
| Simple control of nose bleed | 13 | $1,307 | $82 |
| Injection of drug or substance under skin or into muscle | 35 | $962 | $26 |
| Test to assess middle ear function | 26 | $391 | $13 |
| Injection, methylprednisolone acetate, 80 mg | 37 | $175 | None |
Drugs they prescribed that Part D paid
$7,964
Pharmacies billed $7,964 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 246) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
234 generic and 12 brand-name prescriptions · $7,964 in drug cost · 49 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 40 | $1,141 | $29 |
| Fluocinolone Acetonide Oil | 34 | $932 | $27 |
| Azelastine | 25 | $606 | $24 |
| Mupirocin | 39 | $332 | $9 |
| Amoxicillin | 21 | $78 | $4 |
See all 6 drugs
| Ipratropium | 40 | $1,141 | $29 |
| Fluocinolone Acetonide Oil | 34 | $932 | $27 |
| Azelastine | 25 | $606 | $24 |
| Mupirocin | 39 | $332 | $9 |
| Amoxicillin | 21 | $78 | $4 |
| Pantoprazole | 13 | $60 | $5 |
Year by year
| 2024 | 246 | 145 | 0% (0) | 5% | $7,964 |
| 2023 | 284 | 163 | 0% (0) | 5% | $11,601 |
| 2022 | 359 | 211 | None | None | $14,495 |
| 2021 | 309 | 158 | None | 4% | $11,799 |
| 2020 | 243 | 128 | 0% (0) | 6% | $9,857 |
| 2019 | 261 | 145 | None | 4% | $11,418 |
| 2018 | 252 | 136 | None | 9% | $12,657 |
| 2017 | 256 | 135 | None | 12% | $12,837 |
| 2016 | 284 | 147 | None | 14% | $12,801 |
| 2015 | 294 | 147 | 5% (16) | 18% | $14,586 |
| 2014 | 289 | 122 | 6% (17) | 18% | $16,752 |
| 2013 | 304 | 138 | 6% (19) | 27% | $18,793 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Ipratropium | 57 | $2,840 | $50 |
| Azelastine | 65 | $1,783 | $27 |
| Ciprofloxacin-Dexamethasone | 12 | $1,721 | $143 |
| Fluocinolone Acetonide Oil | 30 | $1,364 | $45 |
| Azelastine-Fluticasone | 12 | $1,138 | $95 |
| Pantoprazole | 17 | $241 | $14 |
| Mupirocin | 25 | $228 | $9 |
| Amoxicillin | 12 | $66 | $6 |
2022: 8 drugs
| Azelastine | 78 | $3,764 | $48 |
| Ipratropium | 64 | $2,973 | $46 |
| Fluocinolone Acetonide Oil | 40 | $2,157 | $54 |
| Ciprofloxacin-Dexamethasone | 12 | $2,023 | $169 |
| Fluticasone Propionate | 24 | $489 | $20 |
| Mupirocin | 38 | $381 | $10 |
| Pantoprazole | 22 | $327 | $15 |
| Amoxicillin | 15 | $74 | $5 |
2021: 6 drugs
| Azelastine | 70 | $2,288 | $33 |
| Ipratropium | 51 | $1,994 | $39 |
| Fluocinolone Acetonide Oil | 23 | $1,573 | $68 |
| Pantoprazole | 15 | $325 | $22 |
| Mupirocin | 27 | $239 | $9 |
| Fluticasone Propionate | 23 | $234 | $10 |
2020: 6 drugs
| Ipratropium | 59 | $2,424 | $41 |
| Azelastine | 44 | $1,605 | $36 |
| Fluocinolone Acetonide Oil | 13 | $751 | $58 |
| Fluticasone Propionate | 14 | $351 | $25 |
| Mupirocin | 16 | $135 | $8 |
| Amoxicillin | 11 | $67 | $6 |
2019: 6 drugs
| Ipratropium | 63 | $2,148 | $34 |
| Fluocinolone Acetonide Oil | 21 | $1,845 | $88 |
| Azelastine | 36 | $1,566 | $43 |
| Pantoprazole | 12 | $396 | $33 |
| Mupirocin | 18 | $145 | $8 |
| Amoxicillin | 15 | $104 | $7 |
2018: 7 drugs
| Dymista | 12 | $2,792 | $233 |
| Ipratropium | 59 | $2,295 | $39 |
| Fluocinolone Acetonide Oil | 13 | $1,542 | $119 |
| Azelastine | 22 | $1,091 | $50 |
| Mupirocin | 26 | $237 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $162 | $12 |
| Amoxicillin | 12 | $70 | $6 |
2017: 8 drugs
| Ipratropium | 63 | $2,736 | $43 |
| Dymista | 15 | $2,673 | $178 |
| Fluocinolone Acetonide Oil | 17 | $2,425 | $143 |
| Azelastine | 16 | $833 | $52 |
| Fluticasone Propionate | 15 | $214 | $14 |
| Mupirocin | 24 | $196 | $8 |
| Amoxicillin-Clavulanate Potass | 12 | $181 | $15 |
| Amoxicillin | 16 | $86 | $5 |
2016: 8 drugs
| Dymista | 11 | $2,607 | $237 |
| Fluocinolone Acetonide Oil | 15 | $2,140 | $143 |
| Ipratropium | 53 | $1,127 | $21 |
| Azelastine | 15 | $833 | $56 |
| Fluticasone Propionate | 35 | $691 | $20 |
| Mupirocin | 29 | $325 | $11 |
| Pantoprazole | 12 | $175 | $15 |
| Amoxicillin | 14 | $83 | $6 |
2015: 9 drugs
| Ciprodex | 13 | $2,303 | $177 |
| Fluocinolone Acetonide Oil | 14 | $2,224 | $159 |
| Azelastine | 18 | $1,442 | $80 |
| Ipratropium | 40 | $844 | $21 |
| Fluticasone Propionate | 52 | $725 | $14 |
| Hydrocodone-Acetaminophen | 15 | $325 | $22 |
| Mupirocin | 23 | $210 | $9 |
| Pantoprazole | 11 | $150 | $14 |
| Amoxicillin | 15 | $83 | $6 |
2014: 6 drugs
| Fluticasone Propionate | 88 | $1,675 | $19 |
| Ipratropium | 26 | $715 | $28 |
| Azelastine | 12 | $707 | $59 |
| Hydrocodone-Acetaminophen | 11 | $284 | $26 |
| Mupirocin | 13 | $130 | $10 |
| Amoxicillin | 11 | $84 | $8 |
2013: 9 drugs
| Nasonex | 28 | $3,851 | $138 |
| Ciprodex | 22 | $3,242 | $147 |
| Ipratropium | 24 | $613 | $26 |
| Fluticasone Propionate | 23 | $547 | $24 |
| Amox Tr-Potassium Clavulanate | 16 | $312 | $19 |
| Mupirocin | 16 | $209 | $13 |
| Hydrocodone-Acetaminophen | 17 | $155 | $9 |
| Amoxicillin | 16 | $135 | $8 |
| Sodium Chloride | 22 | $66 | $3 |
Money from drug and device companies
$23 in 2024
| 2024 | 1 | 1 | None | $23 |
| 2019 | 3 | 3 | None | $101 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $23 | 1 payment
|
See the published payment
| Inspire Medical Systems | Meals · 2024-12-23 | Inspire | $23 |
See earlier years (2019)
2019: $101
| Intersect ENT | Propel | $39 | 1 payment
|
| Medtronic USA | Nuvent | $39 | 1 payment
|
| OptiNose US | Xhance | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033136916
- Licence
- CA G71603California G71603: Current · expires 2028-08-31
- Trained
- Yale University School of Medicine, 1989 · 37 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G716030
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 100 S Ellsworth Ste 308, San Mateo, CA, 94401
- NPI first listed
- 2006-07-16
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.